Consultations

Recent consultations NPPG has responded to (Dec 2015 – Oct 2017)

NICE

  • Attention deficit hyperactivity disorder (update). December 2015. Scoping workshop attended by one NPPG member.
  • Mental health problems in people with a learning disability. April 2016.
  • Scoping Workshop and Consultation Invitation (Professional): Urea cycle disorders – glycerol phenylbutyrate [ID942]. April 2016. One specialist NPPG member attended the scoping workshop.
  • Rheumatoid Arthritis scope. One NPPG member selected to attend scoping workshop in April 2016.
  • Renal Replacement scoping workshop. Volunteers requested, and one NPPG member selected to attend the workshop. May 2016.
  • Oral health promotion in the community (Quality Standard). June 2016.
  • End of life care for infants, children and young people. August 2016.
  • Vaccine uptake in under 19s (Quality Standard). September 2016.
  • Asthma management: draft guideline consultation. February 2017.
  • Specialist Neonatal Care draft scope consultation. February 2017.
  • Parenteral nutrition in neonates. Scoping workshop attended March 2017 by NPPG member. Successful representation for paediatric pharmacist on guideline committee. Draft scope consultation. April 2017.
  • End of life care for infants, children and young people: Quality standard consultation. May 2017.
  • Cystic fibrosis – diagnosis and management. June 2017.
  • Sinusitis (acute) antimicrobial prescribing. June 2017.
  • Sore throat (acute): antimicrobial prescribing: Draft guidance consultation. August 2017.
  • Attention deficit hyperactivity disorder (update). October 2017.
  • Otitis media (acute): antimicrobial prescribing. October 2017.

EMA

  • We will be responding to the reflection paper on the use of extrapolation in the development of medicines for paediatrics over the next months
  • Comments submitted on Changes to Orphan Drugs article. February 2016
  • ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population. April 2017

NHS Improvement

  • Never Events policy and framework review 2016 – circulated to members for individual comment

NHS England

  • Specialised Services clinical commissioning policies and service specification – 3rd wave. Comments submitted on ivacaftor and aztreonam lysine in cystic fibrosis. March 2016.
  • Engagement on proposed revisions to Clinical Reference Groups in specialised commissioning. March 2016.
  • Specialised Services clinical commissioning policies and service specification – 7th wave. Comments submitted on obesity in surgery. April 2016.
  • Developing a method to assist investment decisions in specialised commissioning. May 2016.
  • Commissioning Policies: Funding of Treatment outside of Clinical Commissioning Policy or Mandated NICE Guidance – A. In-year service development, B. Individual Funding Requests, C. Funding for experimental and unproven treatments, D. Continuing funding after clinical trials. October 2016. Circulated to members for individual comment.
  • Consultation on the Clinical Commissioning Policy Proposition: Commissioning Medicines in Children. October 2016. Circulated to members for individual comment.

GPhC

  • Consultation on standards for pharmacy professionals. June 2016. Circulated to members for individual comment.
  • Continuing Professional Development: 2016 consultation – circulated to members for individual comment

RPS

  • Specials Guidance for Prescribers. December 2015.
  • Professional standards for hospital pharmacy services. September 2017.
  • We will be responding to the draft Professional Guidance on the Safe and Secure Handling of Medicines in the coming months

NMC

  • Consultation on prescribing and standards for medicines management. September 2017.

SIGN

  • British guideline on the management of asthma. April 2016.
error: Content is protected !!

START TYPING AND PRESS ENTER TO SEARCH